Nanodiagnostics as a field makes use of fundamental advances in nanobiotechnology to
diagnose, characterize and manage disease at the molecular scale. As these strategies …

The discipline of neurotheranostics was forged to improve diagnostic and therapeutic
clinical outcomes for neurological disorders. Research was facilitated, in largest measure …

Early noninvasive screening and regression therapy for vulnerable atherosclerotic plaques
remain challenging. In this study, it is aimed to develop a new approach for the active …

As nanotechnologies advance into clinical medicine, novel methods for applying
nanomedicine to cardiovascular diseases are emerging. Extensive research has been …

Cardiovascular diseases (CVDs) are classed as diseases of aging, which are associated
with an increased prevalence of atherosclerotic lesion formation caused by such diseases …

Liposomes are potential drug carriers for atherosclerosis therapy due to low immunogenicity
and ease of surface modifications that allow them to have prolonged circulation half-life and …

Cardiovascular complications derivate from atherosclerosis are the main cause of death in
western world. An early detection of vulnerable atherosclerotic plaques is primordial for a …

Vascular disease is a leading cause of death and disability worldwide. Current surgical
intervention and treatment options for vascular diseases have exhibited limited long-term …

Cardiac catheterization is an invasive diagnostic procedure for treating the cardiovascular
diseases. This paper aims to understand the transport phenomena of blood nanofluid …

Cardiovascular disease poses a significant threat to human health in today's society. A
major contributor to cardiovascular disease is atherosclerosis (AS). The development of …